Eventide Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Eventide Asset Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-621,000	Closed	-$84.7M	–	172
2020 Q3	$84.7M	Hold	621,000	–	–	1.66%	15
2020 Q2	$60M	Hold	621,000	–	–	1.3%	23
2020 Q1	$29.1M	Hold	621,000	–	–	0.94%	40
2019 Q4	$45.3M	Hold	621,000	–	–	1.28%	31
2019 Q3	$32.4M	Hold	621,000	–	–	1.07%	32
2019 Q2	$31.1M	Buy	621,000 +184,000	+42%	+$8.96M	0.95%	35
2019 Q1	$22.7M	Buy	437,000 +135,000	+45%	+$6.22M	0.78%	48
2018 Q4	$14.8M	Hold	302,000	–	–	0.65%	55
2018 Q3	$19.7M	Hold	302,000	–	–	0.72%	49
2018 Q2	$15M	Buy	302,000 +150,000	+99%	+$7.26M	0.62%	59
2018 Q1	$7.42M	Buy	152,000 +42,000	+38%	+$2.18M	0.35%	76
2017 Q4	$4.63M	Buy	110,000 +37,000	+51%	+$1.43M	0.24%	86
2017 Q3	$3.13M	Buy	+73,000	New	+$2.33M	0.18%	90

Eventide Asset Management's MYOK Position: Q4 2020 in Review

Eventide Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 621,000 shares — an estimated $84.7M sold.

Eventide Asset Management first reported a position in MYOK in Q3 2017 and held it in 13 quarters. The position peaked at $84.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Eventide Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Eventide Asset Management sold 621,000 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $84.7M.
Eventide Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
Eventide Asset Management's MyoKardia, Inc. Common Stock position peaked at $84.7M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Eventide Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.